|Kate Rausch||Head, Investor Relations|
|Paul Bolno||President and Chief Executive Officer|
|Mike Panzara||Chief Medical Officer Head, Therapeutics Discovery and Development|
|Chandra Vargeese||Chief Technology Officer, Head of Platform Discovery Sciences|
|Kyle Moran||Chief Financial Officer|
Good morning and welcome to the Wave Life Sciences’ Second Quarter 2022 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.
As a reminder, this call is being recorded and webcast. I will now turn the call over to Kate Rausch, VP of Investor Relations and Corporate Affairs at Wave Life Sciences. Please go ahead.\